Literature DB >> 12473761

Outcomes of 32 hemispherectomies for Sturge-Weber syndrome worldwide.

Eric H Kossoff1, Carol Buck, John M Freeman.   

Abstract

BACKGROUND: Epilepsy affects 80% of patients with Sturge-Weber syndrome; the majority of seizures begin before the age of 1. When seizures are intractable to medications and unihemispheric, hemispherectomy is often advised.
OBJECTIVE: To examine the natural history of patients who underwent hemispherectomy and identify the outcomes in terms of seizure reduction, cognition, and motor deficits.
METHODS: A questionnaire was mailed to the parents of patients identified by the Sturge-Weber Foundation as having had a hemispherectomy between 1979 and 2001. Forty-six percent (32/70) of the parents responded.
RESULTS: The mean age at onset of seizures was 4 months, and the median age at surgery was 1.2 years. Children had failed to respond to 3.7 anticonvulsants prior to surgery and averaged 387 seizures/month. Forty-seven percent had complications (e.g., hemorrhage and hypertension) in the perioperative period; however, 81% are currently seizure-free, with 53% off anticonvulsants. Hemispherectomy type (anatomic versus functional versus hemidecortication) did not influence outcome. Age at onset of seizures did not predict seizure freedom; however, an older age at hemispherectomy was positively correlated. Postoperative hemiparesis was not more severe than before surgery. Cognitive outcome was not related to the age at operation, side of operation, or seizure freedom.
CONCLUSIONS: Children undergoing hemispherectomy presented at a young age and had frequent seizures for approximately 1 year but are now mostly seizure-free. Age at surgery did not have an adverse effect on either seizure or cognitive outcomes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473761     DOI: 10.1212/01.wnl.0000035639.54567.5c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Current Therapeutic Options in Sturge-Weber Syndrome.

Authors:  Anne Comi
Journal:  Semin Pediatr Neurol       Date:  2015-11-11       Impact factor: 1.636

Review 2.  Presentation, diagnosis, pathophysiology, and treatment of the neurological features of Sturge-Weber syndrome.

Authors:  Anne M Comi
Journal:  Neurologist       Date:  2011-07       Impact factor: 1.398

3.  Doing resilience with "half a brain:" navigating moral sensibilities 35 years after hemispherectomy.

Authors:  Andrew R Hatala; James B Waldram; Margaret Crossley
Journal:  Cult Med Psychiatry       Date:  2013-03

4.  Hemispherectomy in pediatric patients with epilepsy: a study of 45 cases with special emphasis on epileptic syndromes.

Authors:  Roberto Caraballo; Marcelo Bartuluchi; Ricardo Cersósimo; Alejandra Soraru; Hugo Pomata
Journal:  Childs Nerv Syst       Date:  2011-09-27       Impact factor: 1.475

Review 5.  Sturge-Weber syndrome.

Authors:  C Di Rocco; G Tamburrini
Journal:  Childs Nerv Syst       Date:  2006-07-06       Impact factor: 1.475

6.  Sturge-weber syndrome.

Authors:  Catherine D Bachur; Anne M Comi
Journal:  Curr Treat Options Neurol       Date:  2013-10       Impact factor: 3.598

Review 7.  Updates and future horizons on the understanding, diagnosis, and treatment of Sturge-Weber syndrome brain involvement.

Authors:  Warren Lo; Douglas A Marchuk; Karen L Ball; Csaba Juhász; Lori C Jordan; Joshua B Ewen; Anne Comi
Journal:  Dev Med Child Neurol       Date:  2011-12-23       Impact factor: 5.449

8.  Early diagnosis of cerebral involvement in Sturge-Weber syndrome using high-resolution BOLD MR venography.

Authors:  Hans-J Mentzel; Andrea Dieckmann; Clemens Fitzek; Ulrich Brandl; Jürgen R Reichenbach; Werner A Kaiser
Journal:  Pediatr Radiol       Date:  2004-10-06

Review 9.  [Sturge-Weber syndrome].

Authors:  W Reith; U Yilmaz; A Zimmer
Journal:  Radiologe       Date:  2013-12       Impact factor: 0.635

10.  Imaging increased glutamate in children with Sturge-Weber syndrome: Association with epilepsy severity.

Authors:  Csaba Juhász; Jiani Hu; Yang Xuan; Harry T Chugani
Journal:  Epilepsy Res       Date:  2016-02-27       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.